Your search for ‘Ropes & Gray’ returned 3,799 results

The China Food and Drug Administration ("CFDA") recently announced several draft rules, most notably, the Draft Amendment of the Provisions for Drug Registration (also known as the Drug Registration Rules, DRR) and the Draft Administrative Regulations on the Review and Approval of Drug Contract Manufacturing ("Draft Contract Manufacturing Rules), which will significant impact the pharmaceutical industry. The CFDA is soliciting public comments on both Rules through early December, 2013.

On January 10, 2018, the China Food and Drug Administration announced the implementation of the Technical Guidelines Governing Acceptance of Medical Device Clinical Data from Foreign Studies.